Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38410742
Comparison of Antidiabetic Medications during the Treatment of Atherosclerosis in T2DM Patients.Dipeptidyl peptidase-4 inhibitor gemigliptin protects against vascular calcification in an experimental chronic kidney disease and vascular smooth muscle cells.Associations of dipeptidyl peptidase-4 inhibitors with mortality in hospitalized heart failure patients with diabetes mellitus.Saxagliptin: A Review in Type 2 Diabetes.Cardiovascular benefits of the newer medications for treating type 2 diabetes mellitusChronic unpredicted mild stress-induced depression alter saxagliptin pharmacokinetics and CYP450 activity in GK ratsInhibiting DPP4 in a mouse model of HHT1 results in a shift towards regenerative macrophages and reduces fibrosis after myocardial infarction.Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus.Impact of fibroblast growth factor 21 on the secretome of human perivascular preadipocytes and adipocytes: a targeted proteomics approach.
P2860

Cardiovascular effects of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes.

Item
http://www.wikidata.org/entity/Q38410742
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Cardiovascular effects of dipe ...... patients with type 2 diabetes.
@en
type
label
Cardiovascular effects of dipe ...... patients with type 2 diabetes.
@en
prefLabel
Cardiovascular effects of dipe ...... patients with type 2 diabetes.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Cardiovascular effects of dipe ...... patients with type 2 diabetes.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921